Deutsche Bank
MITO

Deutsche Bank’s Stealth BioTherapeutics Corp. ADS MITO Stock Holding History

Deutsche Bank’s Portfolio MITO Stock Details MITO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-9,800
Closed -$12K – 4536
2020
Q1 		$12K Buy
+9,800
New +$21.8K ﹤0.01% 4032
2019
Q4 		– Sell
-348
Closed -$2K – 5199
2019
Q3 		$2K Buy
348
+133
+62% +$1.36K ﹤0.01% 4791
2019
Q2 		$2K Buy
+215
New +$2.88K ﹤0.01% 5200

Other funds holding MITO

PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PC
PA Capital Richmond, Virginia $142M AUM 46.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank's MITO Position: Q2 2020 in Review

Deutsche Bank sold out of Stealth BioTherapeutics Corp. ADS (MITO) in Q2 2020, closing a stake of 9,800 shares — an estimated $12K sold.

Deutsche Bank first reported a position in MITO in Q2 2019 and held it in 3 quarters. The position peaked at $12K in Q1 2020. 9 funds tracked by Wall St. Rank hold MITO as of Q2 2020.

  • Deutsche Bank reported no remaining Stealth BioTherapeutics Corp. ADS position as of Q2 2020 after selling out during the quarter.
  • Deutsche Bank sold 9,800 Stealth BioTherapeutics Corp. ADS shares in Q2 2020, an estimated $12K.
  • Deutsche Bank first reported a position in Stealth BioTherapeutics Corp. ADS in Q2 2019 and held it in 3 quarters.
  • Deutsche Bank's Stealth BioTherapeutics Corp. ADS position peaked at $12K in Q1 2020.
  • 9 funds tracked by Wall St. Rank held Stealth BioTherapeutics Corp. ADS as of Q2 2020.

Based on Deutsche Bank's 13F filing for Q2 2020, filed 13 Aug 2020.